Table 2.
Antioxidant Intervention | Animal Models | Species/Gender | Age at Evaluation (Week) | Reprogramming Effects | Ref. |
---|---|---|---|---|---|
Natural antioxidants | |||||
Vitamin C 350 mg/kg/day i.p. daily at gestational day 8 to 14 | Prenatal LPS Exposure |
SD rat/M | 12 | ↓ BP | [82] |
α-tocopherol 350 mg/kg/day via gavage at gestational day 13 to 20 | Prenatal LPS Exposure |
Wistar rat/M | 28 | ↓ BP | [67] |
l-arginine, l-taurine, Vitamins C and E 2 weeks before until 8 weeks after birth | Genetic hypertension | SHR/M and F | 9 | ↓ BP | [83] |
l-arginine, l-taurine, Vitamins C and E 2 weeks before until 8 weeks after birth | Genetic hypertension | SHR/M and F | 50 | ↓ BP, ↓ proteinuria | [84] |
l-arginine, l-taurine, Vitamins C and E 2 weeks before until 4 weeks after birth | Genetic hypertension | FHH rat/M and F | 36 | ↓ BP, ↓ proteinuria, ↓ glomerulosclerosis | [85] |
0.25% l-citrulline in drinking water in pregnancy and lactation | Maternal caloric restriction diet, 50% | SD rat/M | 12 | ↓ kidney injury, ↑ nephron number | [29] |
0.25% l-citrulline in drinking water in pregnancy and lactation | Maternal streptozotocin -induced diabetes | SD rat/M | 12 | ↓ BP, ↓ kidney injury | [32] |
0.25% l-citrulline in drinking water in pregnancy and lactation | Prenatal dexamethasone exposure | SD rat/M | 12 | ↓ BP | [35] |
0.25% l-citrulline in drinking water 2 weeks before until 6 weeks after birth | Genetic hypertension | SHR/M and F | 50 | ↓ BP | [86] |
l-tryptophan 200 mg/kg BW/day via oral gavage in pregnancy | Maternal adenosine-induced CKD | SD rat/M | 12 | ↓ BP, ↓ Cr level | [60] |
BCAA-supplemented diet in pregnancy |
Maternal caloric Restriction, 70% |
SD rat/M | 16 | ↓ BP | [87] |
0.01% melatonin in drinking water in pregnancy and lactation | Maternal caloric restriction | SD rat/M | 12 | ↓ BP | [30] |
0.01% melatonin in drinking water in pregnancy and lactation | Maternal l-NAME exposure | SD rat/M | 12 | ↓ BP | [34] |
0.01% melatonin in drinking water in pregnancy and lactation | Maternal methyl-donor diet | SD rat/M | 12 | ↓ BP | [59] |
0.01% melatonin in drinking water in pregnancy and lactation | Maternal constant light exposure | SD rat/M | 12 | ↓ BP | [88] |
0.01% melatonin in drinking water in pregnancy and lactation | Maternal high-fructose diet, 60% | SD rat/M | 12 | ↓ BP | [89] |
0.01% melatonin in drinking water in pregnancy and lactation | Maternal high-fructose diet plus post-weaning high-salt diet | SD rat/M | 12 | ↓ BP | [90] |
0.01% melatonin in drinking water in pregnancy and lactation | Prenatal dexamethasone exposure | SD rat/M | 16 | ↓ BP | [91] |
0.01% melatonin in drinking water in pregnancy and lactation | Prenatal dexamethasone exposure plus post-weaning high-fat diet | SD rat/M | 16 | ↓ BP | [92] |
Melatonin 10 mg/kg/day in drinking water in pregnancy | Genetic hypertension model | SHR/M | 16 | ↓ BP | [93] |
0.05% resveratrol in drinking water in pregnancy and lactation | Maternal TCDD and dexamethasone exposures | SD rat/M | 16 | ↓ BP | [62] |
50 mg/L resveratrol in drinking water in pregnancy and lactation | Maternal bisphenol A exposure and high-fat diet | SD rat/M | 16 | ↓ BP | [63] |
50 mg/L resveratrol in drinking water in pregnancy and lactation | Maternal plus post-weaning high-fructose diet | SD rat/M | 12 | ↓ BP | [58] |
50 mg/L resveratrol in drinking water in pregnancy and lactation | Maternal l-NAME plus postnatal high-fat diet | SD rat/M | 16 | ↓ BP | [94] |
Synthetic antioxidants | |||||
Lazaroid 10 mg/kg/day via gavage in pregnancy | Maternal low protein diet, 9% | Wistar rat/M | 12 | ↓ BP | [31] |
MitoQ 500 µM in drinking water in pregnancy and lactation | Maternal smoking exposure | Balb/c mice/M | 13 | ↓ BP, ↓ kidney injury, ↑ nephron number | [70] |
Dimethyl fumarate 50 mg/kg/day via gavage in pregnancy | Prenatal dexamethasone and postnatal high-fat diet |
SD rat/M | 16 | ↓ BP | [95] |
Tempol 172 mg/L in drinking water 2 weeks before until 8 weeks after birth | Genetic hypertension | SHR/Mand F | 50 | ↓ BP, ↓ proteinuria | [96] |
1% NAC in drinking water in pregnancy and lactation |
Suramin administration | SD rat/M | 12 | ↓ BP | [33] |
1% NAC in drinking water in pregnancy and lactation |
Maternal l-NAME exposure |
SD rat/M | 12 | ↓ BP | [34] |
1% NAC in drinking water in pregnancy and lactation |
Prenatal dexamethasone and postnatal high-fat diet |
SD rat/M | 12 | ↓ BP | [36] |
1% NAC in drinking water in pregnancy and lactation |
Genetic hypertension model | SHR rat/M | 12 | ↓ BP | [97] |
Studies tabulated according to types of antioxidant intervention, animal models and age at evaluation. BP = blood pressure. CKD = chronic kidney disease. Cr = creatinine. FHH = Fawn hooded hypertensive rat. L−NAME = NG−nitro−L−arginine−methyl ester. M = male. F = female. NAC = N-acetylcysteine. BCAA = branched-chain amino acid. LPS = lipopolysaccharide. SD = Sprague-Dawley rat. SHR = spontaneously hypertensive rat. TCDD = 2,3,7,8-tetrachlorodibenzo-p-dioxin; ↑= increased; ↓= decreased.